Abbott Laboratories (ABT)
Add to Watchlists Create an Alert
37.49
-0.23 -0.61%
NYSE
May 23, 1:35PM
BATS Real time
Currency in USD
Abbott Laboratories Revenue Quarterly YoY Growth:
-43.13% for Dec. 31, 2012Abbott Laboratories Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -43.13% |
| Dec. 31, 2012 | 4.43% |
| Sept. 30, 2012 | -0.44% |
| June 30, 2012 | 1.98% |
| March 31, 2012 | 4.60% |
| Dec. 31, 2011 | 4.11% |
| Sept. 30, 2011 | 13.17% |
| June 30, 2011 | 8.95% |
| March 31, 2011 | 17.44% |
| Dec. 31, 2010 | 13.40% |
| Sept. 30, 2010 | 11.77% |
| June 30, 2010 | 17.76% |
| March 31, 2010 | 14.59% |
| Dec. 31, 2009 | 10.56% |
| Sept. 30, 2009 | 3.52% |
| June 30, 2009 | 2.47% |
| March 31, 2009 | -0.70% |
| Dec. 31, 2008 | 10.09% |
| Sept. 30, 2008 | 17.58% |
| June 30, 2008 | 14.81% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
ABT Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 8.46% |
| Pfizer | -12.37% |
| Eli Lilly and Company | 0.00% |
ABT Revenue Quarterly YoY Growth Rankings
| Overall |
41st percentile 4704 of 8006 |
| Sector |
32nd percentile 463 of 686 in Healthcare |
| Industry |
9th percentile 84 of 93 in Medical Devices |
ABT Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -43.13% | Mar 2013 |
| Maximum | 17.76% | Jun 2010 |
| Average | 6.35% |
